@article{bae355a557b140d181c823f6ef585362,
title = "Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists",
keywords = "Alzheimer's disease, glucagon-like peptide-1, insulin resistance, type 2 diabetes, Glucagon-Like Peptide-1 Receptor/metabolism, Glucagon-Like Peptide 1/metabolism, Humans, Dementia/drug therapy, Syndrome, Animals, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents/therapeutic use, Brain/metabolism, Glucagon-Like Peptide-1 Receptor Agonists",
author = "Yassine, \{Hussein N.\} and Victoria Solomon and Angad Thakral and Nasim Sheikh-Bahaei and Chui, \{Helena C.\} and Braskie, \{Meredith N.\} and Schneider, \{Lon S.\} and Konrad Talbot",
note = "Publisher Copyright: {\textcopyright} 2021 The Authors. Alzheimer's \& Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.",
year = "2022",
month = mar,
doi = "10.1002/alz.12474",
language = "English",
volume = "18",
pages = "478--497",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
number = "3",
}